System and method related to augmenting an immune system

• US 20060047435A1
• Filed: 08/24/2004
• Published: 03/02/2006
• Est. Priority Date: 08/24/2004
• Status: Abandoned Application

• Current Assignee: Searete LLC (Intellectual Ventures LLC)
• Original Assignee: Searete LLC (Intellectual Ventures LLC)
• Inventors: Ishikawa, Muriel Y., Myhrvold, Nathan P., Wood, Lowell L. Jr., Jung, Edward K.Y., Wilson, Richa
• Application Number:
  US10/925,905
• Publication Number:
  US 20060047435A1
• Time in Patent Office: Days
• US Class Current: 702/19
• CPC Class Codes: A61K 39/00 Medicinal preparations containing antigens or antibodies materials for immunoassay G01N33/53
• CPC Class Codes: C07K 16/00 Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies antibodies with enzymatic activity, e.g. abzymes C12N9/0002
• CPC Class Codes: Y02A 50/30 Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

The present application relates, in general, to a system and/or method for detection and/or treatment.

Claims

1. A method, comprising:

identifying an association of at least a portion of one or more agents with at least a part of an immune response;

projecting a pattern of changes relating to the at least a portion of the one or more agents; and

selecting one or more immune response components in response to the projecting.

2. The method of claim 1, wherein the selecting one or more immune response components further comprises:

selecting at least a part of one or more of a macrophage, a lymphocyte, a T-lymphocyte, a killer T-lymphocyte, a immune response modulator, a helper T-lymphocyte, an antigen receptor, an antigen presenting cell, a cytotoxic T-lymphocyte, a T-8 lymphocyte, a cluster differentiation (CD) molecule, a CD3 molecule, or a CD1 molecule.

3. The method of claim 1, wherein the selecting one or more immune response components further comprises:

selecting one or more modulators of at least a part of at least one of a macrophage, a lymphocyte, a T-lymphocyte, a killer T-lymphocyte, an immune response modulator, a helper T-lymphocyte, an antigen receptor, an antigen presenting cell, a cytotoxic T-lymphocyte, a T-8 lymphocyte, a cluster differentiation (CD) molecule, a CD3 molecule, or a CD1 molecule.

4. The method of claim 1, wherein the selecting one or more immune response components further comprises:

selecting one or more of modulators of at least a part of a B lymphocyte.

5. The method of claim 1, wherein the selecting one or more immune response components further comprises:

selecting one or more of modulators of at least a part of a at least one of B-lymphocyte.

6. The method of claim 1, wherein the selecting one or more immune response components further comprises:

selecting at least a part of one or more of an antibody, a recombinant antibody, a genetically engineered antibody, a chimeric antibody, a monospecific antibody, a bispecific antibody, a multispecific antibody, a diabody, a chimeric antibody, a humanized antibody, a human antibody, a heteroantibody, a monoclonal antibody, a polyclonal antibody, or an antibody fragment.

7. The method of claim 1, wherein the selecting one or more immune response components further comprises:

selecting one or more of a modulator of at least a part of at least one of an antibody, a recombinant antibody, a genetically engineered antibody, a chimeric antibody, a monospecific antibody, a bispecific antibody, a multispecific antibody, a diabody, a chimeric antibody, a humanized antibody, a human antibody, a heteroantibody, a monoclonal antibody, a polyclonal antibody, or an antibody fragment.

8. The method of claim 1, wherein the identifying an association of at least a portion of one or more agents with a part of an immune response further comprises:

identifying an association of at least a portion of at least one of a virus, a bacterium, a yeast, a mold, a fungus, a mycoplasma, a ureaplasma, a Chlamydia, a rickettsia, a nanobacterium, a prion, an agent responsible for TSE, a multicellular parasite, a protein, an infectious protein, a nucleic acid, a metabolic by-product, a cellular by-product, or a toxin.

9. A system, comprising:

circuitry for associating at least a portion of one or more agents with at least a part of an immune response;

circuitry for projecting a pattern of changes relating to the at least a portion of the one or more agents; and

circuitry for selecting one or more immune response components responsive to said circuitry for projecting.

10. The system of claim 9, wherein the circuitry for selecting one or more immune response components further comprises:

circuitry for selecting at least a part of one or more of a macrophage, a lymphocyte, a T-lymphocyte, a killer T-lymphocyte, a immune response modulator, a helper T-lymphocyte, an antigen receptor, an antigen presenting cell, a cytotoxic T-lymphocyte, a T-8 lymphocyte, a cluster differentiation (CD) molecule, a CD3 molecule, or a CD1 molecule.

11. The system of claim 9, wherein the circuitry for selecting one or more immune response components further comprises:

circuitry for selecting one or more modulators of at least a part of at least one of a macrophage, a lymphocyte, a T-lymphocyte, a killer T-lymphocyte, an immune response modulator, a helper T-lymphocyte, an antigen receptor, an antigen presenting cell, a cytotoxic T-lymphocyte, a T-8 lymphocyte, a cluster differentiation (CD) molecule, a CD3 molecule, or a CD1 molecule.

12. The system of claim 9, wherein the selecting one or more immune response components further comprises:

circuitry for selecting one or more of modulators of at least a part of a B lymphocyte.

13. The system of claim 9, wherein the circuitry for selecting one or more immune response components further comprises:

circuitry for selecting one or more of modulators of at least a part of a at least one of B-lymphocyte.

14. The system of claim 9, wherein the circuitry for selecting one or more immune response components further comprises:

circuitry for selecting at least a part of one or more of an antibody, a recombinant antibody, a genetically engineered antibody, a chimeric antibody, a monospecific antibody, a bispecific antibody, a multispecific antibody, a diabody, a chimeric antibody, a humanized antibody, a human antibody, a heteroantibody, a monoclonal antibody, a polyclonal antibody, or an antibody fragment.

15. The system of claim 9, wherein the circuitry for selecting one or more immune response components further comprises:

circuitry for selecting one or more of a modulator of at least a part of at least one of an antibody, a recombinant antibody, a genetically engineered antibody, a chimeric antibody, a monospecific antibody, a bispecific antibody, a multispecific antibody, a diabody, a chimeric antibody, a humanized antibody, a human antibody, a heteroantibody, a monoclonal antibody, a polyclonal antibody, or an antibody fragment.

16. The system of claim 9, wherein the circuitry for identifying an association of at least a portion of one or more agents with a part of an immune response further comprises:

circuitry for identifying an association of at least a portion of at least one of a virus, a bacterium, a yeast, a mold, a fungus, a mycoplasma, a ureaplasma, a Chlamydia, a rickettsia, a nanobacterium, a prion, an agent responsible for TSE, a multicellular parasite, a protein, an infectious protein, a nucleic acid, a metabolic by-product, a cellular by-product, or a toxin.

17. A method, comprising:

accepting an input of one or more agents; and

identifying an association of at least a portion of one or more agents with at least a part of an immune response related to eradicating the one or more agents.

18. A system, comprising:

circuitry for accepting an input of one or more agents; and

circuitry identifying an association of at least a portion of one or more agents with at least a part of an immune response related to eradicating the one or more agents.

19. A method, comprising:

projecting a pattern of changes relating to the at least a portion of one or more agents; and

selecting one or more immune response components in response to said projecting.

20. A system, comprising:

circuitry for projecting a pattern of changes relating to the at least a portion of one or more agents; and

circuitry for selecting one or more immune response components in response to said projecting.